![]()

Lucid’s pledge to improve patient outcomes through
pioneering medical education programmes has been recognised at the PMEA this
year. The company won its first award of the night in the category “Excellence
in Rare Diseases and Orphan Drugs” for the EIDON programme, which focuses on
establishing specialist care for patients with hidradenitis suppurativa. The
second award went to the OptiMiSe team in the category “Excellence in
Healthcare Professional Education and Support” for their multi-channel learning
platform. OptiMiSe is aimed at multiple sclerosis specialist nurses, and helps
them overcome behavioural barriers to improve MS management.
Jan Steele (Lucid co-founder and COO) commented:
“2017 has been a magical year for everybody at Lucid. We feel privileged to
work with clients who share the same passion and ambition to make a difference.
It’s wonderful to see that our work, and our commitment to transforming the
lives of those we touch, has been recognised at the PMEA.”